
The following statement can be attributed to BIO's President and CEO Dr. Michelle McMurry-Heath:
“President Biden has long been a champion of research to end cancer. He reaffirmed that commitment today with the relaunch of the "Cancer Moonshot."
"Though details are still forthcoming, BIO welcomes this initiative and stands united with the President's goal of ending the untold human suffering from cancer.
"In the coming weeks, we look forward to working with the White House as it develops a long-term strategy, especially as it relates to understanding the effects of all healthcare policies on the development of future cancer cures."
Discover More
Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance …
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement.“The passage of the Mikaela Naylon Give Kids a Chance Act is a bipartisan victory for children and…
Biotechnology Innovation Organization
1201 New York Avenue NW, Suite 1300, Washington, DC, 20005 ・ 202-962-9200
© BIO 2025 All Rights Reserved